Master Revised Schedule M - New Critical Requirements for Manufacture of Oral Solid Dosage Forms

About the Webinar:
Pharma Best Practices Foundation is pleased to invite you to a webinar where we delve into the intricacies of the Revised Schedule M, focusing specifically on its impact and specific requirements for the manufacture of oral solid dosage forms such as tablets and capsules.
This webinar focusing on tablets and capsules explores the specific requirements outlined in the Revised Schedule M. From formulation and manufacturing processes to packaging and labelling standards, we elucidate the guidelines tailored to ensure the quality and integrity of oral solid dosage forms.
We will also address common implementation hurdles and offer insights into best practices and strategies to streamline compliance while maintaining operational efficiency.
About Mr. Vipul Doshi
Mr. Vipul Doshi has been in pharmaceutical Industry from more than three decades with diverse leadership and operational expertise across development, manufacturing, R&D, GXP quality assurance (QA) and manufacturing operations (parenterals, solid dosage forms, biotechnology, transdermal, biologics and vaccines). He has been a leading advocate for Global Competitiveness and instrumental in due diligence for various acquisitions and mergers. He possesses great expertise in Projects and Engineering for developing Infrastructures for APIs and Drug Products (Sterile and Non Sterile). He has been actively involved with various professional associations like ISPE/PDA/AAM.
Associated with varied Roles and increasing responsibilities he is currently CHIEF QUALITY & COMPLIANCE OFFICER at Zydus Lifesciences Limited (Company has headquarters at Ahmedabad). He also Leads IRA, Research and Development functions for Active Pharmaceutical Ingredient, Environment Health & Safety and Pharmacovigilance.